---
figid: PMC11431580__curroncol-31-00397-g002
figtitle: Schematic presentation of the interaction between estrogen receptor (ER)
  and the PI3K/AKT/mTOR pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC11431580
filename: curroncol-31-00397-g002.jpg
figlink: /pmc/articles/PMC11431580/figure/F2/
number: F2
caption: Schematic presentation of the interaction between estrogen receptor (ER)
  and the PI3K/AKT/mTOR pathway. They converge on activating CDK4/6, leading to phosphorylation
  of Rb and releasing E2F, which, in turn, allows the progression of the cell cycle
  from the G1 to the S phase. Multiple therapeutic agents can be used to block the
  steps of such pathways [17,18]
papertitle: Therapeutic Prospects of Abemaciclib for Patients with Endometrial Cancer
reftext: Ahmad Awada, et al. Curr Oncol. 2024 Sep;31(9).
year: '2024'
doi: 10.3390/curroncol31090397
journal_title: Current Oncology
journal_nlm_ta: Curr Oncol
publisher_name: MDPI
keywords: endometrial cancer | abemaciclib | cyclin-dependent kinase inhibitor | antitumor
  | clinical response | breast cancer
automl_pathway: 0.919537
figid_alias: PMC11431580__F2
figtype: Figure
redirect_from: /figures/PMC11431580__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11431580__curroncol-31-00397-g002.html
  '@type': Dataset
  description: Schematic presentation of the interaction between estrogen receptor
    (ER) and the PI3K/AKT/mTOR pathway. They converge on activating CDK4/6, leading
    to phosphorylation of Rb and releasing E2F, which, in turn, allows the progression
    of the cell cycle from the G1 to the S phase. Multiple therapeutic agents can
    be used to block the steps of such pathways [17,18]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLK3
  - TP53
  - TP63
  - TP73
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - CCNB1
  - CCNB2
  - CCNB3
  - CDK1
  - CDKN2A
  - H3P10
  - CCNA1
  - CCNA2
  - CDK2
  - WARS1
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - CCNE1
  - CCNE2
  - CCND1
  - CCND2
  - CCND3
  - CDK6
  - CDK4
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK5
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - plk3
  - tp53
  - cdkn1a
  - cdk1
  - cdkn2a/b
  - cdk2
  - cdk6
  - cdk4
  - mtor
  - Aromatase inhibitors
  - Estradiol
---
